4-Chlorotestosterone acetateCAS# 855-19-6 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 855-19-6 | SDF | Download SDF |
| PubChem ID | 13327 | Appearance | Powder |
| Formula | C21H29ClO3 | M.Wt | 364.9 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | [(8R,9S,10R,13S,14S,17S)-4-chloro-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate | ||
| SMILES | CC(=O)OC1CCC2C1(CCC3C2CCC4=C(C(=O)CCC34C)Cl)C | ||
| Standard InChIKey | XYGMEFJSKQEBTO-KUJXMBTLSA-N | ||
| Standard InChI | InChI=1S/C21H29ClO3/c1-12(23)25-18-7-6-14-13-4-5-16-19(22)17(24)9-11-20(16,2)15(13)8-10-21(14,18)3/h13-15,18H,4-11H2,1-3H3/t13-,14-,15-,18-,20+,21-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
4-Chlorotestosterone acetate Dilution Calculator
4-Chlorotestosterone acetate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.7405 mL | 13.7024 mL | 27.4048 mL | 54.8095 mL | 68.5119 mL |
| 5 mM | 0.5481 mL | 2.7405 mL | 5.481 mL | 10.9619 mL | 13.7024 mL |
| 10 mM | 0.274 mL | 1.3702 mL | 2.7405 mL | 5.481 mL | 6.8512 mL |
| 50 mM | 0.0548 mL | 0.274 mL | 0.5481 mL | 1.0962 mL | 1.3702 mL |
| 100 mM | 0.0274 mL | 0.137 mL | 0.274 mL | 0.5481 mL | 0.6851 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Ajugamarin chlorohydrin
Catalog No.:BCN3664
CAS No.:85447-27-4
- Caffeic anhydride
Catalog No.:BCN3295
CAS No.:854237-32-4
- (R)-(-)-Rolipram
Catalog No.:BCC5429
CAS No.:85416-75-7
- S- (+)-Rolipram
Catalog No.:BCC2303
CAS No.:85416-73-5
- Rilmenidine Phosphate
Catalog No.:BCC5637
CAS No.:85409-38-7
- Ropivacaine mesylate
Catalog No.:BCC9137
CAS No.:854056-07-8
- (-)-Haplomyrfolin
Catalog No.:BCN3225
CAS No.:85404-48-4
- Norcaesalpinin E
Catalog No.:BCN7006
CAS No.:854038-96-3
- Dasatinib hydrochloride
Catalog No.:BCC1517
CAS No.:854001-07-3
- OGT 2115
Catalog No.:BCC7458
CAS No.:853929-59-6
- NVP-BAG956
Catalog No.:BCC1813
CAS No.:853910-02-8
- (+)-AJ 76 hydrochloride
Catalog No.:BCC6747
CAS No.:85378-82-1
- Eupatorin
Catalog No.:BCN4405
CAS No.:855-96-9
- PK 11195
Catalog No.:BCC6745
CAS No.:85532-75-8
- Safflor Yellow A
Catalog No.:BCN2408
CAS No.:85532-77-0
- NBI-74330
Catalog No.:BCC4111
CAS No.:855527-92-3
- Rhodionin
Catalog No.:BCN1248
CAS No.:85571-15-9
- Kurarinol
Catalog No.:BCN3447
CAS No.:855746-98-4
- Zaltidine
Catalog No.:BCC2068
CAS No.:85604-00-8
- Gynuramine
Catalog No.:BCN2085
CAS No.:85611-43-4
- (2-Aminoethyl)phosphinic acid
Catalog No.:BCN1761
CAS No.:85618-16-2
- Temozolomide
Catalog No.:BCC4386
CAS No.:85622-93-1
- WP1130
Catalog No.:BCC3686
CAS No.:856243-80-6
- Boc-Ala-NH2
Catalog No.:BCC3046
CAS No.:85642-13-3
4-Chlorotestosterone acetate metabolites in cattle after intramuscular and oral administrations.[Pubmed:9590370]
Clin Chem. 1998 May;44(5):973-84.
The use of 4-Chlorotestosterone acetate by farmers for cattle fattening was recently demonstrated although the use of this anabolic steroid is strictly forbidden in the European Union. We investigated the metabolism of 4-Chlorotestosterone acetate in the bovine species after intramuscular and oral administration. Nineteen metabolites were detected in urine after intramuscular injection, and eight metabolites were identified. For this purpose, preparative HPLC, mass spectrometry with different ionization modes (electronic impact and chemical ionization), and different acquisition techniques were used (high resolution, selected ion monitoring, and scan measurement). Metabolite stereoisomerism was determined on the basis of retention time and organic synthesis. 4-Chloroepitestosterone (M2), 4-chloroandrost-4-en-3alpha-ol-17-one (M3), and 4-chloroandrost-4-ene-3,17-dione (M4) were identified as the main urinary markers of intramuscular administration. On the other hand, 4-chloroandrost-4-ene-3alpha,17beta-diol (M7), 4-chloroandrostan-3beta-ol-17-one (M5), and M2 were the primary indicators of an oral administration. In addition, we have shown that 95% of the metabolites were sulfo-conjugated, except for M3, which was partially conjugated to glucuronic acid. Finally, the main metabolites (M2, M3, and M4) were easily identified for 1.5 months after intramuscular administration.
